4.4 Review

Research challenges in central nervous system manifestations of inborn errors of metabolism

Journal

MOLECULAR GENETICS AND METABOLISM
Volume 102, Issue 3, Pages 326-338

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymgme.2010.11.164

Keywords

Inborn errors of metabolism; Central nervous system; Rare disease; Orphan drug designation; Translational research

Funding

  1. NIH Office Rare Diseases Research, National Institute of Neurological Disorders and Stroke
  2. FDA Center for Drug Evaluation and Research, Division of Gastroenterology
  3. National Institute of Child Health and Development Intramural Research Program
  4. Batten Disease Support and Research Association [R01NS060022]
  5. Lysosomal Disease Network
  6. NS065768-01
  7. Urea Cycle Disorders Consortium NIH [RR019453]
  8. National Institute of Neurological Disorders and Stroke [NS054242]
  9. Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD057136]
  10. Food and Drug Administration [FD003450]
  11. Genzyme Corporation
  12. Stem Cells Inc.

Ask authors/readers for more resources

The Research Challenges in CNS Manifestations of Inborn Errors of Metabolism workshop was designed to address challenges in translating potential therapies for these rare disorders, and to highlight novel therapeutic strategies and innovative approaches to CNS delivery, assessment of effects and directions for the future in the treatment of these diseases. Therapies for the brain in inborn errors represent some of the greatest challenges to translational research due to the special properties of the brain, and of inborn errors themselves. This review covers the proceedings of this workshop as submitted by participants. Scientific, ethical and regulatory issues are discussed, along with ways to measure outcomes and the conduct of clinical trials. Participants included regulatory and funding agencies, clinicians, scientists, industry and advocacy groups. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available